Tci Wealth Advisors, Inc. Keros Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$41.44 - $59.32 $3,025 - $4,330	73 New	73 $3,000
Q2 2022 Jul 19, 2022	SELL	$26.03 - $67.04 $1,978 - $5,095	-76 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$42.12 - $59.36 $3,201 - $4,511	76 New	76 $4,000
Q2 2021 Aug 02, 2021	SELL	$42.4 - $70.11 $1,272 - $2,103	-30 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$54.0 - $75.28 $1,620 - $2,258	30 New	30 $2,000

174

30.3M

76.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.44B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.